News 17 Jun 2026 DNDi and Medicines for Malaria Venture (MMV) pool regulatory expertise to accelerate access to lifesaving medicines
Stories 17 Jun 2026 The DNDi-MMV Joint Regulatory Platform: ‘a pioneering programme project for non-profit medical research organizations to speak with one voice’
Press Releases Translations 12 Jun 2026 La RDC approuve l’utilisation de l’acoziborole, un traitement oral à dose unique contre la maladie du sommeil
Press releases 12 Jun 2026 DRC approves the use of acoziborole, a breakthrough one-day oral treatment against sleeping sickness
Statements 9 Jun 2026 DNDi Statement at the UN Multi-Stakeholder Hearing on Pandemic Prevention, Preparedness, and Response (PPPR)
Press releases 8 Jun 2026 DNDi, GARDP, and MMV join forces to accelerate drug development for patients in greatest need
Scientific articles 5 Jun 2026 Severe visceral leishmaniasis in Ethiopia: Outcomes, co-infections and mortality in a prospective real-world cohort PLOS Neglected Tropical Diseases
Scientific articles 29 May 2026 From invisibility to political power: Policy lessons from a decade of Brazil’s Social Forum for Infectious and Neglected Diseases PLOS Neglected Tropical Diseases
Scientific articles 14 May 2026 In vitro profiling of Trypanosoma cruzi inhibitors identified from high throughput screening and application to parasite painting International Journal for Parasitology: Drugs and Drug Resistance
Statements 15 May 2026 DNDi statement on hantavirus outbreak: ‘Investment in pandemic preparedness efforts remains insufficient.’
Scientific articles 13 May 2026 Chemical genetics reveals Leishmania KKT2 and CRK9 kinase activity is required for cell cycle progression PLOS Pathogens
Press releases 12 May 2026 DNDi welcomes GHIT support for global evaluation and registration of fosravuconazole for eumycetoma, in collaboration with Eisai
In the media 29 Apr 2026 Thailand approves ravidasvir, a new drug for hepatitis C, increasing chances of complete cure Thai Rath
Press releases 13 Apr 2017 First large-scale survey of Chagas disease in the United States confirms that the “Silent Killer” is a major public health challenge for the country
Press releases 30 Mar 2017 Daiichi Sankyo announces collaborative research on drugs for neglected diseases
Press releases 14 Feb 2017 Study confirms key therapeutic advance for children living with HIV and tuberculosis
Press releases 22 Oct 2016 African eye worm is worse than it looks: new study shows that the disease leads to increased mortality
Press releases 22 Sep 2016 Global Antibiotic Research & Development Partnership receives financial support from Swiss Government
Press releases 14 Jul 2016 “Towards Ending the Neglect?” DNDi releases update on its Paediatric HIV Programme
Press releases 15 Jun 2016 Celgene joins DNDi’s ‘Drug Discovery Booster’ to accelerate discovery of new treatments for neglected diseases
Press releases 8 Jun 2016 DNDi, Mundo Sano and Chemo team up to register benznidazole in US and Latin America
Press releases 1 Jun 2016 DNDi response to Government of Japan replenishment of The Global Health Innovative Technology Fund
Press releases 24 May 2016 Global Antibiotic Research & Development Partnership (GARDP) garners key financial support for launch
Press releases 13 Apr 2016 Drugs for Neglected Diseases initiative and Pharco Pharmaceuticals to test affordable hepatitis C regimen with support of Malaysian and Thai governments
Press releases 13 Jan 2016 Clinical Research Malaysia and the Drugs for Neglected Diseases initiative sign agreement to launch clinical studies for a public health approach to hepatitis C in Malaysia
Press releases 14 Dec 2015 DNDi statement on KaloBios’ intention to raise price of Chagas drug and file for FDA priority review
Press releases 30 Nov 2015 World AIDS Day 2015: Study begins in Kenya for recently-approved paediatric HIV treatment
Press releases 16 Oct 2015 Drugs for Neglected Diseases initiative unveils new plan for neglected patients at a key gathering of experts in India
